Drughub Market launched in late 2023 as a response to the growing instability of darknet markets. According to forum data from 2024, over 60% of markets active in 2022 had either exit-scammed or been seized by law enforcement by mid-2023. The founders of Drughub—veterans of the Tor community—recognized the need for a market that prioritized transparency, security, and user autonomy. Unlike platforms that rely on centralized escrow or opaque vendor ratings, Drughub implemented a hybrid model combining multisig escrow with community-moderated feedback, reducing the risk of exit scams while maintaining user control over funds.
The mission of Drughub is simple: to provide a stable, drughub market address that users can trust. This commitment is reflected in its uptime records, which consistently exceed 98%—a rarity in the darknet space. Mirror uptime records from 2025 show that Drughub’s primary .onion address and its verified mirrors remained accessible even during periods of heightened Tor network congestion, a testament to its robust infrastructure.
From the outset, Drughub has emphasized harm reduction. The market’s rules explicitly prohibit the sale of fentanyl, counterfeit medications, and other high-risk substances. Instead, it focuses on harm-minimization products, such as testing kits and safer-use supplies, alongside its broader catalog. This ethos has earned Drughub a reputation as a market that balances commerce with community safety.